New York bills · 2025 Regular Session
New York S 10136
Relates to capping cost sharing for antiviral COVID-19 therapeutics
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Became law
Sponsors
- Erik Bottcher (Democratic)
Summary
Official abstract published by the New York legislature
Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Apr 30, 2026 · Senate
REFERRED TO INSURANCE